Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

See Locations Near You

Summary

This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Advanced solid tumors.
Able to swallow oral medication.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

52

Study ID:

NCT00148902

Recruitment Status:

Completed

Sponsor:

GlaxoSmithKline

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

GSK Investigational Site
Detroit Michigan, 48201, United States
GSK Investigational Site
Nashville Tennessee, 37203, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

52

Study ID:

NCT00148902

Recruitment Status:

Completed

Sponsor:


GlaxoSmithKline

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider